22. Reittie JE, Gottlieb DJ, Heslop HE, Leger O, Drexler HG, Hazlehurst G, 
Hoffbrand AV, Prentice HG, Brenner MK. Endogenously activated killer cells 
circulate after autologous and allogeneic marrow transplantation but not after 
chemotherapy. Blood 73:1351-1358,1989. 
23. Heslop HE, Gottlieb DJ, Reittie JE, Bello-Femandez C, Meager A, Prentice 
HG, Brenner MK. Spontaneous and Interleukin 2 induced secretion of tumour 
necrosis factor and gamma interferon following autologous marrow 
transplantation or chemotherapy. Br J Haematol 72:122-126, 1989. 
24. Rencher SD, Hanif I, Heslop HE, Turner V, Brenner MK, Hurwitz JL. 
Reconstitution of the T-cell receptor a 6 repertoire in recipients of allogeneic 
bone marrow transplant. Bone Marrow Transplant (In press). 
25. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. 
Restoration of viral immunity in immunodeficient humans by the adoptive 
transfer of T cell clones. Science 257:238-241, 1992. 
26. Brenner M, Mirro J,Jr., Hurwitz C, Santana V, Ihle J, Krance R, Ribeiro R, 
Roberts WM, Mahmoud H, Schell M, Garth K: Autologous bone marrow 
transplant for children with AML in first complete remission: use of marker 
genes to investigate the biology of marrow reconstitution and the mechanism of 
relapse. Hum Gene Ther 2:137-159,1991. 
27. Santana VM, Brenner MK, Ihle J, Krance R, Furman W, Bowman L, Ribeiro 
R, Hurwitz C, Mahmoud H, Moen RC, Anderson WF: A phase I trial of 
high-dose carboplatin and etoposide with autologous marrow support for 
treatment of stage D neuroblastoma in first remission: use of marker genes to 
investigate the biology of marrow reconstitution and the mechanism of relapse. 
Hum Gene Therap 3:257-272,1991. 
28. Santana VM, Brenner MK, Ihle J, Krance R, Furman W, Bowman L, Ribeiro 
R, Hurwitz C, Mahmoud H, Moen RC, Anderson WF: A phase I trial of 
high-dose carboplatin and etoposide with autologous marrow support for 
treatment of relapse/ refractory neuroblastoma without apparent bone marrow 
involvement: use of marker genes to investigate the biology of marrow 
reconstitution and the mechanism of relapse. Hum Gene Ther 2:273-286,1991. 
29. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Anderson WF, Ihle JN. 
Gene marked cells in remission marrow can contribute to relapse after 
autologous bone marrow transplantation. Lancet (In press). 
30. Brenner MK, Rill DR, Holladay M, Heslop HE, Buschle M, Moen RC, Krance 
RA, Anderson WF, Ihle JN. Long-term expression of a transferred gene in 
human hemopoietic cells in vivo (Submitted). 
[216] 
Recombinant DNA Research, Volume 17 
